Search results

Skip to results

Area of interest

Area of interest

Type

Type

Status

Status

Last updated

Last updated

Guidance programme

Advice programme

Showing 1381 to 1395 of 2208 results for guidelines

  1. What is the clinical and cost effectiveness of a combination management strategy consisting of sound therapy and tinnitus support?

    However, the recommendations on tinnitus support and management in this guideline specify that everyone should receive tinnitus support...

    Research recommendation
    Published
    17 March 2020

  2. What is the clinical and cost effectiveness of a combination management strategy consisting of sound therapy and tinnitus support?

    However, the recommendations on tinnitus support and management in this guideline specify that everyone should receive tinnitus support...

    Research recommendation
    Published
    17 March 2020

  3. Maternal request for caesarean birth: What support or psychological interventions would be appropriate for women who have a fear of vaginal childbirth and request a caesarean birth?

    would help to guide the optimal use of these limited resources and future guideline recommendations. Source guidance details Comes from...

    Research recommendation
    Published
    24 April 2023

  4. Methods and approaches for gathering the experiences of people who use adult social care services:- When conducting research for the purposes of service improvement, what research methods are acceptable, appropriate and effective in meaningfully gathering the views and experiences of people who use services?

    Social Care User Experience Survey). However, the evidence reviewed for this guideline suggests that measures of this kind may have...

    Research recommendation
    Published
    14 November 2018

  5. ENDURALIFE powered CRT-D devices for treating heart failure (HTG433)

    Evidence-based recommendations on ENDURALIFE-powered CRT-D devices for treating heart failure.

    HealthTech guidance
    Last updated
    21 July 2021
    View recommendations

    Sections for HTG433

  6. What is the effectiveness of awake body positioning in improving outcomes for people in hospital with COVID-19 who are not intubated and have higher oxygen needs?

    Source guidance details Comes from guidance COVID-19 rapid guideline: managing COVID-19 Number NG191 Date issued March

    Research recommendation
    Published
    9 March 2022

  7. Hyperhidrosis: oxybutynin (ES10)

    Summary of the evidence on oxybutynin for treating hyperhidrosis (excessive sweating) to inform local NHS planning and decision-making

    Evidence summary
    Published
    21 March 2017

  8. Intermittent urinary catheters: catheter selection:- For patients performing intermittent self-catheterisation over the long term, what is the clinical and cost effectiveness of single-use non-coated versus single-use hydrophilic versus single-use gel reservoir versus reusable non-coated catheters with regard to the following outcomes: symptomatic urinary tract infections, urinary tract infection-associated bacteraemia, mortality, patient comfort and preference, quality of life, and clinical symptoms of urethral damage?

    and cost effectiveness. The cost-effectiveness model developed for this guideline combined evidence of clinical effectiveness, costs and...

    Research recommendation
    Published
    9 June 2015

  9. Is obesity an independent risk factor for perinatal morbidity and mortality?

    the woman's preference and obstetric indications in line with the NICE guideline on intrapartum care for health women and babies . There...

    Research recommendation
    Published
    16 August 2019

  10. Organisation of care:- What is the clinical and cost effectiveness of alternative approaches to organising primary care compared with usual care for people with multimorbidity?

    Any explanatory notes(if applicable) Why this is important:- The guideline committee felt that primary care was well suited to managing...

    Research recommendation
    Published
    18 October 2016

  11. Nivolumab for previously treated unresectable advanced or recurrent oesophageal cancer (TA707)

    Evidence-based recommendations on Nivolumab (Opdivo) for previously treated unresectable advanced, recurrent or metastatic oesophageal squamous cell carcinoma in adults.

    Technology appraisal guidance
    Published
    15 June 2021
    View recommendations

    Sections for TA707

  12. Regorafenib for previously treated unresectable or metastatic gastrointestinal stromal tumours (TA488)

    Evidence-based recommendations on on regorafenib (Stivarga) for previously treated gastrointestinal stromal tumours in adults.

    Technology appraisal guidance
    Published
    15 November 2017
    View recommendations

    Sections for TA488

  13. What training, support or interventions help to reduce caring-related accidents or incidents?

    are included in the psychological and emotional support section of this guideline.By consensus, the committee also agreed to add some...

    Research recommendation
    Published
    10 February 2020

  14. What are the information and support needs of parents and carers with babies on parenteral nutrition?

    as encouraging shared decision making, are covered in the NICE clinical guideline on patient experience in adult NHS services. Given...

    Research recommendation
    Published
    17 March 2020

  15. Panobinostat for treating multiple myeloma after at least 2 previous treatments (TA380)

    Evidence-based recommendations on panobinostat (Farydak) for treating multiple myeloma after at least 2 previous treatments.

    Technology appraisal guidance
    Published
    27 January 2016
    View recommendations

    Sections for TA380